INCY.NASDAQIncyte CORP

Form 4: Incyte EVP Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Incyte's EVP and General Counsel, Sheila A. Denton, exercised stock options and subsequently sold an equal number of common shares on November 17, 2025, under a Rule 10b5-1 plan.

Summary

  • Sheila A. Denton, Executive Vice President and General Counsel of Incyte Corp (INCY), reported transactions on November 17, 2025.
  • Denton exercised employee stock options to acquire 278 shares of common stock at a price of $64.25 per share.
  • Immediately following the exercise, Denton sold 278 shares of common stock at a price of $104.36 per share.
  • The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
  • Following these transactions, Denton directly beneficially owns 26,569 shares of common stock.
  • This beneficial ownership includes an aggregate of 25,913 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance units that have not yet vested.
  • Denton also directly beneficially owns 8,883 employee stock options after these transactions.
  • The options exercised were part of a grant from July 15, 2024, which vest in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years, and have an expiration date of July 14, 2034.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While an executive sold shares, it was a pre-planned transaction under a 10b5-1 plan, and the executive realized a profit from option exercise, indicating stock appreciation. The number of shares is relatively small, suggesting it's for personal financial management rather than a significant change in outlook.

Positives

  • The executive realized a profit by exercising in-the-money stock options, indicating the company's stock price has appreciated above the option's exercise price.
  • The transactions were conducted under a Rule 10b5-1 plan, which demonstrates pre-planned selling and can mitigate concerns about opportunistic insider trading.

Negatives

  • The sale of common stock by an executive, even if pre-planned, results in a reduction of direct insider ownership, which some investors might interpret as a slight decrease in management's direct stake in the company's future performance.

Risks

  • While routine, insider sales can sometimes be misinterpreted by the market as a signal of reduced confidence, potentially leading to minor, short-term negative sentiment.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information directly related to broader industry trends or competitive landscape. Such transactions are common for executives managing personal finances and equity compensation.

Stakeholder Impact

  • Shareholders: Minimal direct impact as this is a routine, pre-planned insider transaction involving a small number of shares relative to the company's total outstanding shares. It may be viewed as a slight reduction in direct insider ownership.
  • Employees: No direct impact mentioned.

Key Dates

DateDescription
07/15/2024Implied date of the original employee stock option grant, with vesting commencing after one year.
11/17/2025Date of employee stock option exercise and subsequent sale of common stock.
07/14/2034Expiration date of the employee stock option.

Keywords

Incyte Corp, INCY, Form 4, Insider Transaction, Stock Option Exercise, Common Stock Sale, Rule 10b5-1 Plan, Executive Compensation, Sheila A. Denton

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.